| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT00969306 | Small Cell Lung Cancer | Drug: Chloroquine, A-CQ 100 | Maastricht Radiation Oncology|Maastricht University Medical Center|National Cancer Institute (NCI) | Phase 1 | 2013-09-01 | 2016-09-27 |
| NCT01575782 | Small Cell Lung Cancer | Drug: Chloroquine | Maastricht Radiation Oncology | Phase 1 | 2014-05-01 | 2016-09-27 |
| NCT01546961 | Vivax Malaria | Drug: Chloroquine | University of Oxford | | 2011-06-01 | 2017-01-04 |
| NCT02496741 | Glioma|Cholangiocarcinoma|Chondrosarcoma | Drug: Metformin and chloroquine combination | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 1|Phase 2 | 2015-11-01 | 2015-11-14 |
| NCT02932007 | Atrial Fibrillation | Drug: Chloroquine Phosphate | University of South Florida | Phase 2 | 2017-01-01 | 2017-01-17 |
| NCT02698748 | Malaria | Drug: Chloroquine|Drug: Placebo | Centro de Investigacao em Saude de Manhica | Phase 2|Phase 3 | 2015-01-01 | 2016-02-29 |
| NCT01980745 | Hepatitis, Autoimmune | Drug: Chloroquine diphosphate 250mg|Drug: Placebo | University of Sao Paulo General Hospital | Phase 4 | 2002-02-01 | 2016-10-25 |
| NCT00308620 | HIV Infections | Drug: chloroquine phosphate|Drug: Placebo | University of Minnesota - Clinical and Translational Science Institute|Minnesota Medical Foundation | Phase 2|Phase 3 | 2006-03-01 | 2012-07-09 |
| NCT01023477 | Carcinoma, Intraductal, Noninfiltrating|DCIS|Ductal Carcinoma In Situ | Drug: Chloroquine Standard Dose (500mg/week)|Drug: Chloroquine Low Dose (250mg/week)|Procedure: Breast Biopsy | Inova Health Care Services|George Mason University|University of Pittsburgh|United States Department of Defense|U.S. Army Medical Research and Materiel Command | Phase 1|Phase 2 | 2009-12-01 | 2017-03-07 |
| NCT01078779 | Influenza | Drug: Chloroquine|Drug: Placebo | National University Hospital, Singapore | Phase 2 | 2009-11-01 | 2010-02-28 |
| NCT02463331 | Autoimmune Hepatitis | Drug: Chloroquine diphosphate|Drug: prednisone|Drug: azathioprine | University of Sao Paulo General Hospital | Phase 4 | 2003-05-01 | 2016-12-29 |
| NCT02610686 | Plasmodium Vivax | Drug: Chloroquine | National Institute of Malariology, Parasitology and Entomology, Vietnam|Institute of Tropical Medicine, Belgium | Phase 4 | 2015-03-01 | 2016-03-22 |
| NCT02004314 | HIV | Drug: Chloroquine | CIHR Canadian HIV Trials Network | | 2009-10-01 | 2013-12-03 |
| NCT01894633 | Brain Metastasis | Drug: Chloroquine|Radiation: Total brain radiotherapy | Instituto Nacional de Cancerologia de Mexico | Phase 2 | 2011-05-01 | 2017-03-02 |
| NCT02071537 | Malignant Neoplasm|Solid Tumors | Drug: Chloroquine|Drug: Carboplatin|Drug: Gemcitabine | University of Cincinnati | Phase 1 | 2014-05-01 | 2017-01-05 |
| NCT01814423 | Malaria | Drug: Chloroquine-base 50 mg|Drug: Chloroquine-base 70 mg | Bandim Health Project | Phase 4 | 2013-04-01 | 2014-03-10 |
| NCT02691910 | Malaria, Vivax | Drug: Chloroquine|Drug: Primaquine | Oswaldo Cruz Foundation|University of Sao Paulo | Phase 2|Phase 3 | 2014-08-01 | 2016-02-24 |
| NCT00844207 | Malaria | Drug: Fixed combination of Azithromycin and Chloroquine|Drug: Azithromycin and Chloroquine | Pfizer | Phase 1 | 2009-02-01 | 2009-04-20 |
| NCT00473837 | Malaria Anaemia | Drug: Chloroquine|Drug: Placebo | Medical Research Council Unit, The Gambia | | 2007-07-01 | 2014-10-09 |
| NCT01777477 | Pancreatic Cancer | Drug: Chloroquine|Drug: Gemcitabine | University of Zurich | Phase 1 | 2012-07-01 | 2015-09-21 |
